BiomX Inc. (PHGE)
NYSEAMERICAN: PHGE · Real-Time Price · USD
2.972
+0.222 (8.07%)
Jan 21, 2026, 1:08 PM EST - Market open
BiomX Market Cap
BiomX has a market cap or net worth of $4.54 million as of January 21, 2026. Its market cap has decreased by -68.20% in one year.
Market Cap
4.54M
Enterprise Value
3.86M
1-Year Change
-68.20%
Ranking
Category
Stock Price
$2.97
Market Cap Chart
Since July 17, 2019, BiomX's market cap has decreased from $1.93B to $4.54M, a decrease of -99.77%. That is a compound annual growth rate of -60.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 20, 2026 | 4.20M | 47.06% |
| Dec 31, 2025 | 2.85M | -78.49% |
| Dec 31, 2024 | 13.27M | 3.09% |
| Dec 29, 2023 | 12.87M | 130.01% |
| Dec 30, 2022 | 5.60M | -87.59% |
| Dec 31, 2021 | 45.11M | -69.57% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jul 17, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 929.76B |
| Johnson & Johnson | 526.82B |
| AbbVie | 378.84B |
| UnitedHealth Group | 299.85B |
| AstraZeneca | 289.32B |
| Novartis AG | 278.23B |
| Merck & Co. | 270.12B |
| Novo Nordisk | 261.50B |